Nrx Pharmaceuticals, Inc.
NRXP
Revenue
242.00k
▲242.00k∞%
6 Months ChangeAssets
15.00M
▲10.16M▲209.96%
3 Months ChangeLiabilities
40.75M
▲298.00k▲0.7367%
3 Months ChangeFree Cash Flow
-3.48M
▲191.00k▲5.20%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001437749-24-032705
2024-10-15
Form 8-K
ID: 0001437749-24-031268
2024-10-11
Form 8-K
ID: 0001437749-24-031133
2024-08-20
Form 8-K
ID: 0001437749-24-027383
2024-08-15
Form 8-K
ID: 0001437749-24-026908
2024-08-14
Form 8-K
ID: 0001437749-24-026888
2024-08-14
Form 10-Q
ID: 0001437749-24-026847
2024-08-12
Form 8-K
ID: 0001437749-24-026107
2024-06-27
Form 8-K
ID: 0001104659-24-075722
2024-06-20
Form 8-K
ID: 0001558370-24-009369